How many clinical trials are tracked for impaired glucose tolerance?

22 trials are tracked, 3 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Urology Dermatology Ophthalmology Emergency Medicine Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

Impaired glucose tolerance

Part of Postprandial Hyperglycemia

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for impaired glucose tolerance

22 trials tracked for impaired glucose tolerance: 8 in phase 3 or 4 and 3 with published results. The most-cited published study has 154 citations.

22Trials tracked

8Phase 3 & 4

0Recruiting

3With published results

Phase distribution

Phase 4 4 Phase 3 4 Phase 2 5 Other / NA 9

Phase 4 The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women Completed · 154 cited
Phase 3 Actos Now for Prevention of Diabetes (ACT NOW) Completed · 102 cited
Phase 3 Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM) Completed · 40 cited
Phase 4 Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes Completed
Phase 4 The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes Completed
Phase 4 Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function Completed

Show 16 more trials

Phase 3 Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose Tolerance Completed
Phase 3 Enhancing Fitness in Older Pre-diabetic Veterans Completed
Phase 2 Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk" Completed
Phase 2 Effect of Gymnema Sylvestre on Patients With Impaired Glucose Tolerance. Completed
Phase 2 To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies Completed
Phase 2 Effects of Treatment of Sleep Apnea on Metabolic Syndrome Completed
Phase 2 Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance Completed
N/A Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy Completed
N/A D Vitamin Intervention in VA Completed
N/A Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth Completed
N/A Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance Completed
N/A Effectiveness and Cost-Effectiveness of Fully-Automated Digital vs. Human Coach-Based Diabetes Prevention Programs Completed
N/A Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance Completed
N/A Effect of Dietary Glycemic Index on Beta-cell Function Completed
N/A Voglibose Tablets 0.2 / OD Tablets 0.2 Special Drug Use Surveillance "Long-term Use in Patients With Impaired Glucose Tolerance" Completed
N/A Treating the Endothelium to Restore Insulin Sensitivity Completed

Showing the 22 most-cited and recently-updated of 22 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.